CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Taipei Medical University Hospital
Taipei, Taiwan
Completed
- Memorial Care
Long Beach, California, United States
Not, yet, recruiting - St. Joseph'S Santa Rosa
Santa Rosa, California, United States
Not, yet, recruiting - Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
Completed - Hartford Health Care
Hartford, Connecticut, United States
Not, yet, recruiting - Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States
Ben Weinstein, MDRecruiting - Facility name not stated
Brooksville, Florida, United States
Not, yet, recruiting - Csnf Cancer Specialists of North Florida (qcca)
Jacksonville, Florida, United States
Not, yet, recruiting - Ocala Oncology
Ocala, Florida, United States
Not, yet, recruiting - University Cancer & Blood Center (qcca)
Athens, Georgia, United States
Not, yet, recruiting - Hawaii Cancer Center
Honolulu, Hawaii, United States
Not, yet, recruiting - Edward H. Kaplan Md and Associates
Skokie, Illinois, United States
Edward H Kaplan, M.D.Not, yet, recruiting - Goshen Health
Goshen, Indiana, United States
Not, yet, recruiting - Community Health Network
Indianapolis, Indiana, United States
Not, yet, recruiting - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
Dung Le, MDRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Marios Giannakis, MD, PhDRecruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Aparna Parikh, MDRecruiting - Nebraska Cancer Specialists (qcca)
Omaha, Nebraska, United States
Not, yet, recruiting - Summit Medical Group
Florham Park, New Jersey, United States
Not, yet, recruiting - Duke Cancer Center, Duke University Medical Center
Durham, North Carolina, United States
John Strickler, MDRecruiting - Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
Not, yet, recruiting - Sanford Health
Sioux Falls, South Dakota, United States
Not, yet, recruiting - Baptist Cancer Center
Memphis, Tennessee, United States
Not, yet, recruiting - Start (south Texas Accelerated Research Therapeutics, Llc)
San Antonio, Texas, United States
Completed - Northwest Medical Specialists (qcca)
Tacoma, Washington, United States
Not, yet, recruiting - University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Dustin Deming, M.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2016
- Primary completion
- 31 Mar 2023
- Completion
- 31 Mar 2023
- Last update posted
- 26 Jan 2022
- Registered enrollment
- 72
- Registry id
- NCT02675946
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.